—ILMN
— • —
$120.93
P/E
22.08
PEG
—
FCF Yield
—
Rev Growth YoY
-66.0% YoY
Gross Margin
6661.0%
Health Score
5/10
D/E Ratio
0.73
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this data payload, making it impossible to describe the company's specific business activities or competitive position. What can be assessed is that the stock is priced at $120.93 and carries valuation ratios consistent with a mid-to-large cap profile, though the absence of a market capitalisation figure prevents formal size classification. Given the data limitations, this brief focuses strictly on the quantitative signals available.
Financial Health
**Score: 5/10** The balance sheet shows a manageable debt load, with a Debt/Equity ratio of 0.73x, which is not alarming in isolation. The current ratio of 2.08x suggests the company can cover near-term obligations, a modestly positive sign for liquidity...
Risk Assessment
- **REVENUE CONTRACTION:** Revenue declined 66.0% year-over-year, representing a severe deterioration in top-line momentum with no quarterly trend data available to assess stabilisation. - **DATA INTEGRITY:** Reported gross margin of 6,661% and net margin of 1,957% are almost certainly statistical distortions from an abnormally small revenue base, undermining the reliability of margin analysis. - **FREE CASH FLOW ABSENT:** FCF and FCF yield are both unavailable, preventing any assessment of cash generation quality or capital efficiency. - **TECHNICALS DETERIORATING:** The MACD signal is bearish, and the price is trading below both the 50-day and 200-day moving averages, with a confirmed death cross — a pattern historically associated with continued downward price pressure. - **VALUATION WITHOUT ANCHOR:** Neither DCF model produces a usable fair value estimate, leaving no quantitative floor under the current $120.93 price. ---...